Last reviewed · How we verify

NCT05751005

Collagen Peptide Supplementation and Lifelong Athletes

Completed NA Last updated 2 March 2023
What this trial tests

NA trial testing Collagen Peptides vs. Placebo in Pain in 86 participants. Completed in 4 April 2022.

Timeline
29 November 2018
Primary endpoint
28 May 2020
4 April 2022

Quick facts

Lead sponsorFlorida State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment86
Start date29 November 2018
Primary completion28 May 2020
Estimated completion4 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida State University

Who can join

Adults 40 to 65, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the current research is to evaluate the effects of 6 and 9 months of Solugel® supplementation on joint mobility, comfort, performance, body composition and related biomarkers of joint and bone health in older life-long athletes and physically active people. Doses of zero, 10, and 20 g per day for 6 or 9 months will be administered to determine, if any, is most effective at improving the previously mentioned outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Florida State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05751005.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing